19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  J. Schwitter,et al.  In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI , 2016, PloS one.

[3]  J. Gariépy,et al.  Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer , 2016, Cancer Immunology Research.

[4]  Z. Ram,et al.  Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools , 2016, International reviews of immunology.

[5]  Bryan P Bednarz,et al.  19F-MRI for monitoring human NK cells in vivo , 2016, Oncoimmunology.

[6]  P. Harden,et al.  Regulatory T cells: first steps of clinical application in solid organ transplantation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  J. Bankson,et al.  In Vivo (19)F-Magnetic Resonance Imaging of Adoptively Transferred NK Cells. , 2016, Methods in molecular biology.

[8]  D. Kraitchman,et al.  Fluorine‐19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications , 2015, Stem cells translational medicine.

[9]  Jeffrey A. Bluestone,et al.  Type 1 diabetes immunotherapy using polyclonal regulatory T cells , 2015, Science Translational Medicine.

[10]  A. Bagg,et al.  Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. , 2015, The New England journal of medicine.

[11]  C. Figdor,et al.  PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI. , 2015, Nanomedicine.

[12]  K. Gilbert,et al.  Tracking the Fate of Stem Cell Implants with Fluorine-19 MRI , 2015, PloS one.

[13]  E. Ahrens,et al.  Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI , 2014, Magnetic resonance in medicine.

[14]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[15]  A. Hamilton,et al.  Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[16]  C. Flask,et al.  19F MRI Tracer Preserves in Vitro and in Vivo Properties of Hematopoietic Stem Cells , 2013, Cell transplantation.

[17]  Mathias Hoehn,et al.  Labeling cells for in vivo tracking using (19)F MRI. , 2012, Biomaterials.

[18]  K. Kakimi,et al.  [Dendritic cells for cancer immunotherapy]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[19]  S. Phuphanich,et al.  Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma , 2012, Cancer Immunology, Immunotherapy.

[20]  Mathias Hoehn,et al.  In Vivo Tracking of Human Neural Stem Cells with 19F Magnetic Resonance Imaging , 2011, PloS one.

[21]  Ralf M. Leonhardt,et al.  Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear , 2011, The Yale journal of biology and medicine.

[22]  B. Sangro,et al.  Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients , 2011, The Journal of Immunology.

[23]  M. Levings,et al.  Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model. , 2011, Cytotherapy.

[24]  F. Paul,et al.  Perfluorocarbon Particle Size Influences Magnetic Resonance Signal and Immunological Properties of Dendritic Cells , 2011, PloS one.

[25]  E. Ahrens,et al.  A novel 19F agent for detection and quantification of human dendritic cells using magnetic resonance imaging , 2011, International journal of cancer.

[26]  M. Hellmich,et al.  Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis , 2011, PloS one.

[27]  M. Fishman,et al.  Sipuleucel-T: Prototype for Development of Anti-tumor Vaccines , 2011, Current oncology reports.

[28]  P. Foster,et al.  In Vivo Cellular MRI of Dendritic Cell Migration Using Micrometer-Sized Iron Oxide (MPIO) Particles , 2011, Molecular Imaging and Biology.

[29]  Arend Heerschap,et al.  Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. , 2010, Biomaterials.

[30]  P. Kantoff,et al.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer. , 2010, The New England journal of medicine.

[31]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[32]  E. Ahrens,et al.  Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. , 2010, Cytotherapy.

[33]  Z. Berneman,et al.  Dendritic cell-based cancer gene therapy. , 2009, Human gene therapy.

[34]  D. Laidlaw,et al.  In vivo cytometry of antigen‐specific t cells using 19F MRI , 2009, Magnetic resonance in medicine.

[35]  W. Oyen,et al.  Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients , 2009, Clinical Cancer Research.

[36]  A. Escobar,et al.  Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Mangala Srinivas,et al.  Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model , 2007, Magnetic resonance in medicine.

[38]  Andreas Hess,et al.  In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice , 2006, European journal of immunology.

[39]  P. Schellhammer,et al.  Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[41]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[42]  A. Palucka,et al.  Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.

[43]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[44]  S. Vuk-Pavlović,et al.  Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen‐independent prostate cancer: A phase 2 trial , 2004, The Prostate.

[45]  Antonio Lanzavecchia,et al.  Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.

[46]  W. Oyen,et al.  Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. , 2003, Cancer research.

[47]  R. Kiss,et al.  111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  T. MacVittie,et al.  The impact of recent advances in immunology and cancer therapy on nuclear medicine. , 2001, Seminars in nuclear medicine.

[49]  A. Lanzavecchia,et al.  The Role of Aquaporins in Dendritic Cell Macropinocytosis , 2000, The Journal of experimental medicine.

[50]  W. Oyen,et al.  Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. , 1999, Cancer research.

[51]  M. Foti,et al.  CD14-dependent Endotoxin Internalization via a Macropinocytic Pathway* , 1998, The Journal of Biological Chemistry.

[52]  G. Nossal.  Host immunobiology and vaccine development , 1997, The Lancet.

[53]  F. Herrmann,et al.  Combination of interleukin-2 and interferon-alpha in renal cell carcinoma and malignant melanoma: a phase II clinical trial. , 1992, Biotechnology therapeutics.